Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Health and Human Services Secretary Robert F. Kennedy Jr. is setting his sights on baby formula production, launching a probe with the U.S. Food and Drug Administration (FDA) over contaminants ...

If you are one of the millions of people around the world who recently sat down to watch Adolescence on Netflix, you know why the show has captured the attention of, well, millions of people.

The expanded collaboration now allows Reddit to use Google’s Vertex AI, which enables users to build, deploy, and scale machine learning models and AI applications, the author notes. Easily ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

The 9:5:2 formula promotes better cognitive development, improved academic performance, and a healthier lifestyle. The 9:5:2 formula is not just a routine; it’s a roadmap to success. This is the ...

A federal tax liability is an amount that’s owed to the government in taxes. It can include income taxes on earnings and capital gains taxes on assets. Both are based on brackets, a percentage ...

The Formula 1 2024-25 season is slated to start in the next few days. All the teams have finalised their driver lineups. Now, Alpine F1 team has announced Indian driver Kush Maini as their reserve ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...